CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes

Techniques that enable longitudinal tracking of cell fate after myocardial delivery are imperative for optimizing the efficacy of cell‐based cardiac therapies. However, these approaches have been underutilized in preclinical models and clinical trials, and there is considerable demand for site‐speci...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Stem Cells Transl Med
Hlavní autoři: Ostrominski, John W., Yada, Ravi Chandra, Sato, Noriko, Klein, Michael, Blinova, Ksenia, Patel, Dakshesh, Valadez, Racquel, Palisoc, Maryknoll, Pittaluga, Stefania, Peng, Kah‐Whye, San, Hong, Lin, Yongshun, Basuli, Falguni, Zhang, Xiang, Swenson, Rolf E., Haigney, Mark, Choyke, Peter L., Zou, Jizhong, Boehm, Manfred, Hong, So Gun, Dunbar, Cynthia E.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2020
Témata:
Enabling Technologies for Cell‐based Clinical Translation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7519772/
https://ncbi.nlm.nih.gov/pubmed/32700830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.20-0019
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky